Viva Vax Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Viva Vax General Information

Description

Manufacturer of protective coatings intended to increase the durability of glass surfaces. The company develops a line of performance coatings for glass surfaces that enhance the durability of glass vials, enabling clients to protect drug content from heat during transport and storage and easily operates a biotechnology facility that leverages deep-science technologies to enhance drug delivery.

Contact Information

Website
www.vivavax.org
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 44 Gerrard Street East
  • Toronto, Ontario M5B 1G3
  • Canada
Primary Industry
Industrial Chemicals
Other Industries
Specialty Chemicals
Corporate Office
  • 44 Gerrard Street East
  • Toronto, Ontario M5B 1G3
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viva Vax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 02-Jul-2024 Completed Out of Business
5. Accelerator/Incubator 27-Jun-2019 Completed Startup
4. Accelerator/Incubator 01-Jan-2019 Completed Startup
3. Accelerator/Incubator 01-Jan-2019 Completed Startup
2. Accelerator/Incubator 09-Oct-2017 Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view Viva Vax’s complete valuation and funding history, request access »

Viva Vax Patents

Viva Vax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3123892-A1 Polyurethane with high heat tolerance and other desirable properties including transparency, surface smoothness, desirable adhesiveness, resistance to impact damage, scratches and moisture, and method and use thereof Inactive 07-Jul-2020
WO-2020107105-A1 A gelation/de-gelation system for transdermal delivery of an active ingredient (or substrate) Inactive 26-Nov-2018
JP-2021502278-A Insulation-imparting sugar-based composition and its usage Pending 02-Nov-2017
CA-3079988-A1 Saccharide-based composition for providing thermal insulation and method of use thereof Inactive 02-Nov-2017
US-20190127590-A1 Saccharide-based composition for providing thermal insulation and method of use thereof Inactive 02-Nov-2017 C09D5/00
To view Viva Vax’s complete patent history, request access »

Viva Vax FAQs

  • When was Viva Vax founded?

    Viva Vax was founded in 2016.

  • Where is Viva Vax headquartered?

    Viva Vax is headquartered in Toronto, Canada.

  • What industry is Viva Vax in?

    Viva Vax’s primary industry is Industrial Chemicals.

  • Is Viva Vax a private or public company?

    Viva Vax is a Private company.

  • What is Viva Vax’s current revenue?

    The current revenue for Viva Vax is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process